Stock Updates

Today’s Top Gainers in the Market Mylan N.V. (NASDAQ:MYL) from Healthcare

Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining 0.56% today. In the last week its performance is -0.18%, and -7.94% for the past quarter. Currently, Mylan N.V., MYL has a target price of 58.13, so today’s gain of 0.56% is a significant step towards its target price. The GAP today is therefore 0.23%.

Mylan N.V. (NASDAQ:MYL), has a market cap of 21981.75, and is based in USA. Insider ownership is at 0.70%, and institutional ownership is 71.30%.

At the current price of 43.48, it has a dividend yield of *TBA, and its target price is 58.13. This is with a profit margin of 8.30%, and total debt/equity of 0.73. Mylan N.V. (NASDAQ:MYL) has a P/E of 27.8, as well as a forward P/E of 7.42.

With a current EPS of 1.56, and a forecasted EPS growth for next year at 18.56%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at 20.20%. For the next five years EPS growth is projected to be 13.98%.

Performance for the year is -37.99%. Since its IPO date on 12/18/1987, the total performance to date is -19.59%.

Volume today for Mylan N.V. (NASDAQ:MYL), is 5332339, while its average volume is 5205.82. Whilst the total gain today was 0.56%, it did have a day high of -12.02%.

Volatility for this week has been at 2.56%, and 2.89% for the month. The 52-week low for Mylan N.V., MYL has been 15.67%, while the 52-week-high has reached -41.16%.

Looking at its return of investments, which is 8.20%, and its return on assets is 3.60%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 14.60%. With a sales growth of 17.10% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 0.62, and has a current ratio of 1.7 and 1.1 for quick ratio.

So what is the value of Mylan N.V.? Well its PEG is 1.99, and the P/S is 2.25, along with a P/B of 2.07. Meanwhile it has a p/cash of 18.33.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment